Trial Profile
Therapeutic effect of the Exenatide in the treatment of polycystic ovary syndrome
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Metformin
- Indications Polycystic ovary syndrome
- Focus Pharmacodynamics; Therapeutic Use
- 28 Apr 2016 New trial record